Muscle support formula for semaglutide users
Part of Hormones & metabolism clinical trials.
This study tests a nutritional drink or formula designed to help you keep muscle while you lose weight on semaglutide. It aims to see if the product is safe and well-tolerated during your weight loss journey.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking semaglutide (like Wegovy) for weight loss and are moving to a weekly 1 mg dose.
- Your body mass index (BMI) is between 25 and 35.
- You do not have serious or unstable medical conditions like heart, liver, or kidney problems, or infections like HIV, TB, or hepatitis.
- You are not taking diabetes medications, narcotics, blood thinners, or corticosteroids recently.
- You are willing to follow study rules, including limiting alcohol to no more than one drink per day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
This study tests whether slowly reducing the dose of the weight-loss medication semaglutide can help keep weight off after losing at least 10% of body weight. It compares two ways of tapering the dose to see which works better for maintaining weight loss.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.